Market Cap: $124.76M
HI
Humacyte, Inc.
HUMA
NASDAQ (NASDAQ Global Select)USD
Market Cap: $124.76M
Humacyte Faces Class Action Lawsuits Over Misleading Operational Practices In a significant legal development, Humacyte, Inc. is embroiled in class action lawsuits filed by Rosen Law Firm and Schall L…
Humacyte's Regulatory Challenges Prompt Investor Lawsuits In recent days, Humacyte, Inc. faces legal scrutiny as multiple law firms announce class action lawsuits stemming from significant regulatory…
Regulatory Hurdles for Humacyte's Biologic License Application Raise Concerns Humacyte, Inc., a biotechnology company specializing in regenerative medicine, faces significant regulatory challenges tha…
Humacyte Faces Legal Challenges Amid Regulatory Scrutiny Humacyte, Inc. finds itself in the midst of a class action lawsuit filed by Kirby McInerney LLP in the U.S. District Court for the Middle Distr…
Legal Challenges Ahead for Humacyte Amid FDA Review Concerns Humacyte, Inc., a biotechnology firm specializing in regenerative medicine, faces significant legal challenges following a class action law…
Humacyte Faces Class Action Lawsuit Amid FDA Review Delays In a significant development for Humacyte, Inc., a class action lawsuit has been filed in the U.S. District Court for the Middle District of…
Humacyte Faces Legal Challenges Amid FDA Scrutiny of ATEV Approval Process Humacyte, Inc., a company specializing in regenerative medicine and the development of its acellular tissue engineered vessel…
Humacyte Faces Legal Challenges Amid FDA Scrutiny Humacyte, Inc., a pioneer in the field of regenerative medicine, is currently navigating significant legal challenges as investors file a class action…
### Humacyte Faces Legal Challenges Over Allegations of Misleading Statements Humacyte, Inc., a biotechnology firm specializing in the development and manufacturing of off-the-shelf, implantable bioen…
Humacyte Faces Class Action Lawsuit Amid FDA Compliance Issues Humacyte, Inc., a company focused on regenerative medicine and tissue engineering, is embroiled in a class action lawsuit initiated by Gl…
### Humacyte Faces Class Action Lawsuit Over Alleged Misstatements Humacyte, Inc., a biotechnology company specializing in regenerative medicine, finds itself in the midst of a class action lawsuit in…
Humacyte Faces Regulatory Scrutiny Amid FDA Concerns Humacyte, Inc., a pioneer in the development of acellular tissue engineered vessels (ATEVs) for vascular trauma, is currently under scrutiny due to…